about
Yield of Contrast-Enhanced Power Doppler Endoscopic Ultrasonography and Strain Ratio Obtained by EUS-Elastography in the Diagnosis of Focal Pancreatic Solid Lesions.Surgical treatment of acute abdominal complications in hematology patients: outcomes and prognostic factors.The value of splenectomy in chronic lymphocytic leukemia.The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic targetMolecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic studyComparison of preoperative imaging and pathological findings for pancreatic head adenocarcinoma: A retrospective analysis by the Association Française de Chirurgie.Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group.High incidence of colic anastomotic leakage complicating upper abdominal en bloc evisceration for cancer: a 47-patient series.'Peripheric' pancreatic cysts: performance of CT scan, MRI and endoscopy according to final pathological examinationA multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.Cancers of the biliary system.Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association.A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT.Pancreaticoduodenectomy: Secondary stenting of the celiac trunk after inefficient median arcuate ligament release and reoperation as an alternative to simultaneous hepatic artery reconstruction.Prognostic value of PDL1 expression in pancreatic cancerGene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine effortsGuidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).Isolated pancreatic metastasis from malignant melanoma: is pancreatectomy worthwile?Use of partially covered and uncovered metallic prosthesis for endoscopic ultrasound-guided hepaticogastrostomy: Results of a retrospective monocentric study.Combined NOTES total mesorectal excision and single-incision laparoscopy principles for conservative proctectomy: a single-centre study.Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.Staging of rectal cancer: a prospective study of digital examination and endosonography before and after preoperative radiotherapy.[Analgesic effect of transhiatal splanchnectomy in pain from cancer of the pancreas. Apropos of 51 operated cancers]Transhiatal bilateral splanchnicotomy for pain control in pancreatic cancer: basic anatomy, surgical technique, and immediate results in fifty-one cases.Neoplastic Barrett's oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse.Venous Resection in Pancreatic Ductal Adenocarcinoma: Impact of Surgical Experience on Early Postoperative Courses.Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: Time for a Randomized Controlled Trial? Results of an All-inclusive National Observational Study.Short- and Mid-Term Outcomes after Endoscopic Transanal or Laparoscopic Transabdominal Total Mesorectal Excision for Low Rectal Cancer: A Single Institutional Case-Control Study.Hepaticogastrostomy by echo-endoscopy as a palliative treatment in a patient with metastatic biliary obstruction.Tolerance and feasibility of perioperative treatment with interferon-alpha 2a in advanced cancers.Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.Distant lymph node metastases in gastroesophageal junction adenocarcinoma: impact of endoscopic ultrasound-guided fine-needle aspiration.Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.[Management of localized, locally advanced and metastatic pancreatic adenocarcinoma].Surgical resection of locally recurrent colorectal adenocarcinoma.Interleukin-2 in association with increasing doses of interferon-gamma in patients with advanced cancer.Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence.Short-term outcome after laparoscopic or open restorative mesorectal excision for rectal cancer: a comparative cohort study.
P50
Q30436437-630862CF-6D4A-4AFD-BD2F-64EE4DD7748FQ33439994-2084960C-E38D-43A3-ACCF-EB16713F8552Q33456778-C09395CC-F95A-4000-85E3-D6CF5EB7785CQ33510943-577DE80B-36EF-4CCF-8622-489AE68C8490Q33682949-D559DDA2-1557-46BC-8B6C-CCA33904F4FBQ33818221-483F88BC-1BDC-446F-BA33-603A72C50251Q34702123-EFB1347B-19D1-4B58-9017-90701C074271Q35128347-3FA8524E-C558-4003-B8DF-C10CDAD29305Q35603818-3203BFA6-FB20-4102-9515-E137BD0DA254Q36343813-0D4B870F-5EB7-486C-9D08-C3F3E65CA14CQ36676006-3E7267D0-9F17-4CFA-9550-B0515F29623FQ37480826-4AAB1910-3AF0-4DF3-961F-E60C4459E303Q37480844-AD6CBA22-108E-4E05-8905-8FD642408B05Q37619827-6024897A-DDFE-4CCE-854E-E1621ECAA485Q37629732-1E0970CB-8AB7-4C7D-B50C-83971DE0A93EQ37687595-654FCA22-C18E-48FB-8F45-5DB076834C5DQ37733990-5599A359-36E2-4859-95CD-7CAE7B7DC338Q38254413-E36F836C-28CF-4CD5-A4D6-CAE385BD30B1Q38630416-CCAA8AAA-2DDB-44F8-8FB0-D765BF428B7BQ38689837-7126ECB1-D672-4AEB-A60E-E4FD117AC04CQ38781024-A32D6780-35B4-41A1-AB36-DFD890263964Q39156308-9CF97735-91A0-4953-8117-AEEF8247CE40Q39365352-AF827170-2E88-4833-A9B5-131F9260158BQ39403914-9F5283BD-1533-4288-AD4A-C67901AD9495Q39490129-4B3AE17E-7D9F-4D74-AA6E-CE23B06A212EQ39501790-C950A798-10F2-45DC-ADD3-B31E7D4FA848Q39809188-231408EB-23F9-48DA-958B-85BC613D0279Q40110119-65AC567D-0F6A-4A43-88BF-733528B740E3Q40304004-E23E870E-23B5-4B5E-9BFD-042A11C5833EQ40406972-45597708-8D0B-45F2-9E9A-463262FE458EQ40544850-6601964A-7C7B-4231-B6EB-46C2F73793E8Q40652288-D96317CE-77E9-4088-A054-A780860827F1Q40701248-B8E2535D-6664-46A2-AB2A-90AE090DA25BQ40849631-FF070615-5F9A-4827-A738-6B6CD932AABFQ41441298-A3E55727-B5CD-4385-AA48-B57545E96009Q41714571-4449BC71-127D-424C-8B9B-6A69D01E2B8CQ41732685-43D8600F-C89C-419C-8B9B-4CC03C733752Q41855912-0E5E0A79-338E-4F80-89A1-582909D285C7Q42135896-0DBA0463-28BD-456F-A0AF-F7EDD1F4D76FQ42606924-B286B6F5-D1CC-40E9-A43D-546B4677046B
P50
description
researcher ORCID ID = 0000-0002-0000-1332
@en
wetenschapper
@nl
name
Jean Robert Delpero
@ast
Jean Robert Delpero
@en
Jean Robert Delpero
@es
Jean Robert Delpero
@nl
type
label
Jean Robert Delpero
@ast
Jean Robert Delpero
@en
Jean Robert Delpero
@es
Jean Robert Delpero
@nl
prefLabel
Jean Robert Delpero
@ast
Jean Robert Delpero
@en
Jean Robert Delpero
@es
Jean Robert Delpero
@nl
P106
P31
P496
0000-0002-0000-1332